Registry for Chronic Obstructive Pulmonary Disease With Anxiety and Depression in China
The Early Detection, Clinical Course and Prognosis of Anxiety and Depression in Chronic Obstructive Pulmonary Disease
1 other identifier
observational
1,906
1 country
1
Brief Summary
Anxiety and depression are common comorbidities of chronic obstructive pulmonary disease (COPD). However, the exact prevalence is not known in China. COPD patients with anxiety and depression tend to have more severe symptoms and worse prognosis, but the related evidences are not strong enough. The study aim to investigate the prevalence and long-term outcome of anxiety and depression in COPD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2017
CompletedFirst Posted
Study publicly available on registry
June 14, 2017
CompletedStudy Start
First participant enrolled
June 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedJune 14, 2017
June 1, 2017
3.5 years
June 13, 2017
June 13, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
moderate and severe COPD exacerbations
total times
3 years
Secondary Outcomes (1)
All-cause mortality
3 years
Eligibility Criteria
Stable COPD patients
You may qualify if:
- Stable chronic obstructive pulmonary disease (COPD) patients
You may not qualify if:
- Patients with bronchial asthma or other severe pulmonary diseases or having received pulmonary surgery in 6 months
- Patients with tumor history during past 5 years
- Patients with COPD exacerbations during past 4 weeks
- Participants in clinical trials
- Patients in pregnancy or breastfeeding
- Patients unable to complete questionaire independently
- Patients older than 80 years old
- Patients receiving long-term domiciliary oxygen therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100032, China
Related Publications (1)
Zhao X, Su R, Hu R, Chen Y, Xu X, Yuan Y, Zhang J, Zhang W, Yang Y, Chen M, Li D, Wu B, Huang D, Wu D. Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study. BMC Geriatr. 2023 Feb 11;23(1):89. doi: 10.1186/s12877-023-03784-7.
PMID: 36774462DERIVED
Biospecimen
Serum and blood cells
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief of Pulmonary Vascular Disease Center
Study Record Dates
First Submitted
June 13, 2017
First Posted
June 14, 2017
Study Start
June 15, 2017
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
June 14, 2017
Record last verified: 2017-06